RPTUAS Pharma Subsidy Scheme: ₹2 Crore Support for WHO-GMP & Schedule M Compliance

If you are a pharma manufacturer preparing for Revised Schedule M compliance, the RPTUAS Pharma Subsidy Scheme  (Revamped Pharmaceutical Technology Upgradation Assistance Subsidy) could cover up to ₹2 Crore of your upgrade costs — with no mandatory bank loan required. Here is everything you need to know to check your eligibility and apply.

This scheme is more than just financial help; it is a global opportunity for pharma businesses to modernize, meet global standards, and stay competitive without draining their funds.

What is the RPTUAS?

The RPTUAS pharma subsidy scheme provides subsidy support up to ₹2 Crore for existing pharma units upgrading to Revised Schedule M and WHO-GMP standards.

When these requirements become mandatory, the scheme ensures that companies do not fall behind due to limited financial resources. Whether it is installing new machinery, upgrading clean rooms, or obtaining international certification, RPTUAS reduces the financial burden significantly.

Quick Eligibility Check

RPTUAS vs PTUAS: What Changed?

The RPTUAS is the revamped version of the earlier PTUAS scheme. Here is a quick comparison:

Objectives of the RPTUAS Pharma Subsidy Scheme

The scheme goes beyond reimbursement and has a wide purpose:

• Boost Global Competitiveness: Help Indian pharmaceutical companies and expand their reach in the international Market.
• Promote Quality Standards: Ensure every pharma unit operates under the Revised Schedule M and WHO-GMP guidelines.
• Boost Modernization: Support for advanced technology, equipment, and better infrastructure.
• Reduce the Financial Stress: Make easy compliance for MSME and mid-sized pharma units.

RPTUAS Pharma Subsidy Benefits for Pharma Units 

• Financial Relief: Compliance costs can run very High. With support up to ₹2 Crore, the pharma unit can handle the upgrade without exhausting its resources.
• Better Cash Flow: Applications can be filed even before starting expenditure, helping companies plan without locking up working capital.
• Support for Modernization: Many units delay upgrades because their cost is very high with RPTUAS; modernization becomes possible without heavy financial strain.
• Global Market Access: WHO-GMP Certification improves credibility and opens the door to international trade.
• Long-term Savings: Early compliance avoids penalties, regulatory issues, and the risk of operational shutdowns.

Who Can Apply?

Existing pharma units with an average turnover below ₹500 Cr in the past 3 years.

Subsidy Amount: Turnover-Based Slabs

Eligible Investments

Only expenditure on the following components qualifies for subsidy:

• Utilities (HVAC, water, Steam)
• Clean Room Facility
• Testing Lab, Stability Chamber
• Effluent treatment/waste Management
• Production Equipment
• Consultation/certification Expenses
• Any other item approved by the Technical Committee

How It Works: Implementation & Disbursement

• Online Application: Submit the Gap analysis report through the PMC portal.
• PMC Review: The project management consultant (PMC) reviews and recommends subsidy estimates.
  • PMC can also process loan applications if opted for by the applicant. However, availing a loan is not mandatory for subsidy eligibility.
• SSC Evaluation: PMC forwards proposals to the schemes steering committee.
• First Instalment (up to Rs 1 Cr): After submission of Revised Schedule M and CA-certified expenditure (post 01.01.2024) on eligible investment.
  • PMC verifies, and SSC releases 50% of the eligible amount
• Final Instalment (cumulative max Rs 2 Cr): After submission of the Final WHO-GMP Certificate and the Updated CA-Certified expenditure report, PMC re-verifies and SSC releases the remaining eligible amount.

Note: In Addition to this subsidy, the applicant may also be eligible to claim state government subsidies, subject to applicable state policies and approvals.

Documents Required for RPTUAS Application

• Partnership deed or Incorporation certificate
• Drug manufacturing license from the drug authority
• PAN, GST, and Udyam certificate
• Last 3 years’ audited financial reports
• Gap Analysis Report with details of machinery/utilities to be installed
• Supplier quotation or cost estimates
• Photographs of the manufacturing unit
• KYC of Partners or Directors

Why Should You Act Fast?

Funds under the RPTUAS pharma subsidy scheme are limited and disbursed on a first-come, first-served basis. Delaying your application means missing out while other units move ahead.

For pharma entrepreneurs, upgrading to WHO-GMP and Revised Schedule M is no longer optional — it is essential for regulatory survival and international market access.

FAQ’s

1. Is the subsidy only for existing pharma units?

Yes. The RPTUAS pharma subsidy scheme is meant only for existing pharmaceutical manufacturing units that are engaged in formulations/API/intermediate/bulk Drug Plant/others that are already operational.

2. Who can apply for this scheme?

• Existing pharmaceutical manufacturing unit in India.
• The company’s average turnover should be below ₹500 crores in the past three years.
• The Unit must be planning the upgradation of facilities for the revised schedule M and the WHO GMP as per the new norms.

3. Is taking a bank loan compulsory for getting a subsidy?

No, a bank loan is not compulsory. You can upgrade your plant using your own funds or through a bank loan. The Scheme is accepting both kinds of investment. What matters is that the money is spent on eligible activities (machinery, utilities, compliance upgrades, etc.)

4. What kind of Expenses are covered?

Upgrading in machinery, clean rooms, Quality control systems, HVAC, Production equipment, and certification costs are typically reimbursed.

5. What papers or documents are generally needed?

When applying, pharma companies usually have to keep ready:

• Partnership deed, Incorporation certificate
• Manufacturing license of the drug authority.
• PAN, GST, and Udyam certificate
• Last 3 years’ audited report
• Gap report with details of machinery/utilities to be installed
• Quotation or estimate from suppliers
• Photos of the manufacturing unit
• Partner or Director’s KYC

6. What is the difference between PTUAS and RPTUAS?

RPTUAS is the revamped version of the earlier PTUAS scheme, updated to align with the new Revised Schedule M norms and WHO-GMP requirements. It covers eligible expenditure incurred from January 1, 2024 onwards, and increases the maximum subsidy support to ₹2 Crore.